Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Metrics to compare | GALD | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipGALDPeersSector | |
---|---|---|---|---|
P/E Ratio | −1,988.1x | −0.5x | −0.6x | |
PEG Ratio | - | 0.00 | 0.00 | |
Price/Book | 3.7x | 0.2x | 2.6x | |
Price / LTM Sales | 6.5x | 1.6x | 3.1x | |
Upside (Analyst Target) | −2.0% | 99.3% | 55.4% | |
Fair Value Upside | Unlock | 21.1% | 10.2% | Unlock |